BIOPHARMA CREDIT PLC ORD USD0.0 - stock earnings

BPCR.L Quarterly earnings

DateEarningsRevenue
2023Q2 35.5 million USD 39.3 million USD
2023Q1 35.5 million USD 39.3 million USD
2022Q4 57.1 million USD 71.1 million USD
2022Q3 57.1 million USD 71.1 million USD
2022Q2 34.1 million USD 38.0 million USD
2022Q1 34.1 million USD 38.0 million USD
2021Q2 44.2 million USD 52.0 million USD
2020Q4 48.8 million USD 61.7 million USD
2020Q2 40.4 million USD 48.3 million USD
2019Q4 42.4 million USD 64.1 million USD
2019Q2 30.6 million USD 31.0 million USD
2019Q1 30.6 million USD 31.0 million USD
2018Q4 17.5 million USD 27.6 million USD
2018Q3 17.5 million USD 27.6 million USD
2018Q2 17.5 million USD 19.7 million USD
2018Q1 17.5 million USD 19.7 million USD
2017Q2 7.1 million USD 9.7 million USD

BPCR.L Yearly earnings

DateEarningsRevenue
2022 182.3 million USD 184.2 million USD
2021 85.0 million USD 88.0 million USD
2020 89.1 million USD 91.4 million USD
2019 122.3 million USD 124.1 million USD
2018 70.1 million USD 78.7 million USD
2017 31.7 million USD 39.3 million USD

BPCR.L

Price: $0.85

52 week price:
0.81
1.02

Dividend Yield: 0.08%

5-year range yield:
0.08%
31.06%

Forward Dividend Yield: 9.46%

Payout Ratio: 61.54%

Payout Ratio Range:
61.54%
145.23%

Dividend Per Share: 0.08 USD

Earnings Per Share: 0.13 USD

P/E Ratio: 7.15

Exchange: LSE

Sector: Financial Services

Industry: Asset Management

Market Capitalization: 10.7 million

Average Dividend Frequency: 4

Years Paying Dividends: 8

DGR3: 17.33%

DGR5: 17.60%

Links: